نتایج جستجو برای: transarterial chemoembolization

تعداد نتایج: 4521  

2009
Guido Poggi Laura Villani Giovanni Bernardo

Glucagonomas are pancreatic islet cell tumors arising from the alpha cells which belong to neuroendocrine tumors. They frequently metastasize to the liver. We report the case of a 52- year old man with a pancreatic glucagonoma with synchronous multiple liver metastases treated by surgery, transarterial chemoembolization, percutaneous radiofrequency thermal ablation and long-acting octreotide. O...

2009
Kyu-Ho Choi Young Kwon Cho Jin Kyung An Jeong-Joo Woo Hyun Sook Kim Yun-Sun Choi

Acute obstructive cholangitis due to the migration of necrotized tumor fragment is a rare complication occurring after a transarterial chemoembolization. The percutaneous tumor removal procedure following percutaneous transhepatic biliary drainage is an appropriate treatment over endoscopic removal for the relief of acute cholangitis in this case. Following this serial management, no invasive h...

2009
Artan Reso Chad G Ball Francis R Sutherland Oliver Bathe Elijah Dixon

BACKGROUND Transarterial chemoembolization (TACE) is a well accepted treatment for inoperable hepatocellular carcinoma (HCC). While minor complications involve 10% of all patients, severe complications are rare. CASE PRESENTATION We describe a case of a 90-year-old male with a large, superficial HCC who underwent TACE. He had a significant intraperitoneal bleed secondary to tumor rupture imme...

2013
Simona Ioaniţescu L. Micu Mariana Mihăilă R. Badea

Current treatment of HCC is based on the updated Barcelona algorithm [3]. According to this algorithm, therapeutic options for HCC are divided into curative treatments (resection, liver transplantation and radiofrequency/percutaneous ethanol injection) for HCC in very early stage or early stage (A), transarterial chemoembolization (TACE) for intermediate stage (B) HCC, sorafenib for advanced st...

Journal: :Anticancer research 2013
Yusuke Yamamoto Hisashi Ikoma Ryo Morimura Hirotaka Konishi Yasutoshi Murayama Shuhei Komatsu Atsushi Shiozaki Yoshiaki Kuriu Takeshi Kubota Masayoshi Nakanishi Daisuke Ichikawa Hitoshi Fujiwara Kazuma Okamoto Chouhei Sakakura Toshiya Ochiai Eigo Otsuji

BACKGROUND The aim of this study was to characterize changes in outcome following hepatectomy for hepatocellular carcinoma (HCC) over a 30-year period. PATIENTS AND METHODS The clinical records of 372 patients who underwent a macroscopic curative hepatectomy for treatment of HCC between 1980 and 2009 were retrospectively examined. Patients were divided into two groups: an early group (1980-20...

2017
Zhe Guo Yuan Zhong Bo Hu Jing-Hang Jiang Le-Qun Li Bang-De Xiang

This study aimed to compare the long-term survival of patients with hepatocellular carcinoma (HCC) within the Milan criteria who underwent hepatic resection (HR) or transarterial chemoembolization (TACE).Medical records were retrospectively analyzed for HCC patients within the Milan criteria treated at Affiliated Tumor Hospital of Guangxi Medical University between March 2003 and March 2008, 15...

Journal: :Liver cancer 2015
Tadaaki Arizumi Kazuomi Ueshima Tomohiro Minami Masashi Kono Hirokazu Chishina Masahiro Takita Satoshi Kitai Tatsuo Inoue Norihisa Yada Satoru Hagiwara Yasunori Minami Toshiharu Sakurai Naoshi Nishida Masatoshi Kudo

BACKGROUND AND AIMS Patients with intermediate-stage hepatocellular carcinoma (HCC) refractory to transcatheter arterial chemoembolization (TACE) are considered to be candidates for sorafenib. The aim of this study was to evaluate the superiority of conversion of treatment to sorafenib on overall survival (OS) for cases refractory to TACE. METHODS This was a retrospective cohort study carried...

2017
Waleed Fateen Farooq Khan Richard J O’NeiSSll Martin W James Stephen D Ryder Guruprasad P Aithal

BACKGROUND A meta-analysis comparing drug-eluting beads transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (cTACE) has recently been published. On balance, no significant differences were found in terms of objective response and overall survival. The impact on healthcare costs had been studied in small series based on a hypothetical model and was in fav...

Journal: :Liver cancer 2017
Tadaaki Arizumi Kazuomi Ueshima Mina Iwanishi Tomohiro Minami Hirokazu Chishina Masashi Kono Masahiro Takita Norihisa Yada Satoru Hagiwara Yasunori Minami Hiroshi Ida Yoriaki Komeda Mamoru Takenaka Toshiharu Sakurai Tomohiro Watanabe Naoshi Nishida Masatoshi Kudo

AIM/BACKGROUND The ultimate aim of any treatment for hepatocellular carcinoma (HCC) is to improve overall survival (OS); however, the clinical significance of time to progression (TTP) after transarterial chemoembolization (TACE) is unclear. This retrospective study examined the association between OS and the newly defined time to TACE progression (TTTP) to assess whether TTTP can be an alterna...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید